According to a recent report, the Global Physician Dispensed Cosmeceuticals Market will reach a valuation of $28.3 billion by 2027, growing at a CAGR of 8.7%.
Amid the pandemic, the global market for Physician Dispensed Cosmeceuticals was at $15.7 billion in 2020.
The market is broken into the following segments: skin care, hair care and eye care.
The skin care segment is projected to grow at a 9.9% CAGR and reach $12.8 billion by the end of the analysis period.
The hair care segment is projected to grow at a 8.3% CAGR for the next 7-year period. This segment currently accounts for a 23.2% share of the market.
The eye care segment holds a 18% share of the market, and is projected to grow 7.7% CAGR over the forecast period.
The market in the U.S. is estimated at $5.9 billion 2020, accounting for over 37.6% of the global market.
China is forecast to grow at a 10.9% CAGR by 2027, and is forecast to reach an estimated market size of $2.2 billion.
Oher noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.3% and 7.9% respectively over the forecast period. Within Europe, Germany is forecast to grow at approximately 8% CAGR while rest of European market will reach $2.2 billion by the year 2027.
China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India and South Korea, the market in Asia-Pacific is forecast to reach $2.9 billion by the year 2027, while Latin America will expand at a 8.8% CAGR through the analysis period.
